Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Mind Medicine Inc’s stock clocked out at $5.80, up 2.47% from its previous closing price of $5.66. In other words, the price has increased by $2.47 from its previous closing price. On the day, 0.92 million shares were traded. MNMD stock price reached its highest trading level at $5.9401 during the session, while it also had its lowest trading level at $5.72.
Ratios:
To gain a deeper understanding of MNMD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.00 and its Current Ratio is at 7.20. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on January 28, 2025, initiated with a Outperform rating and assigned the stock a target price of $23.
On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 25 ’25 when Barrow Robert sold 21,208 shares for $6.74 per share. The transaction valued at 142,942 led to the insider holds 856,556 shares of the business.
Karlin Daniel sold 6,836 shares of MNMD for $46,075 on Mar 25 ’25. The Chief Medical Officer now owns 446,177 shares after completing the transaction at $6.74 per share. On Mar 25 ’25, another insider, Sullivan Mark, who serves as the Chief Legal Officer of the company, sold 6,576 shares for $6.74 each. As a result, the insider received 44,322 and left with 316,621 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 437136736 and an Enterprise Value of 185249488.
Stock Price History:
The Beta on a monthly basis for MNMD is 2.72, which has changed by -0.31442082 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $10.44, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is -11.78%, while the 200-Day Moving Average is calculated to be -15.75%.
Shares Statistics:
It appears that MNMD traded 1.93M shares on average per day over the past three months and 1038640 shares per day over the past ten days. A total of 75.37M shares are outstanding, with a floating share count of 74.09M. Insiders hold about 1.10% of the company’s shares, while institutions hold 49.60% stake in the company. Shares short for MNMD as of 1743379200 were 11336926 with a Short Ratio of 5.86, compared to 1740700800 on 11805380. Therefore, it implies a Short% of Shares Outstanding of 11336926 and a Short% of Float of 15.06.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
